[go: up one dir, main page]

JP2006022045A - METHOD FOR ISOLATING AND PURIFYING OPTICALLY ACTIVE 1-t-BUTOXYCARBONYL-3-AMINOPYRROLIDINE SALT - Google Patents

METHOD FOR ISOLATING AND PURIFYING OPTICALLY ACTIVE 1-t-BUTOXYCARBONYL-3-AMINOPYRROLIDINE SALT Download PDF

Info

Publication number
JP2006022045A
JP2006022045A JP2004201784A JP2004201784A JP2006022045A JP 2006022045 A JP2006022045 A JP 2006022045A JP 2004201784 A JP2004201784 A JP 2004201784A JP 2004201784 A JP2004201784 A JP 2004201784A JP 2006022045 A JP2006022045 A JP 2006022045A
Authority
JP
Japan
Prior art keywords
butoxycarbonyl
aminopyrrolidine
optically active
salt
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004201784A
Other languages
Japanese (ja)
Inventor
Kohei Mori
耕平 森
Akira Nishiyama
章 西山
Nobuo Nagashima
伸夫 長嶋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaneka Corp
Original Assignee
Kaneka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp filed Critical Kaneka Corp
Priority to JP2004201784A priority Critical patent/JP2006022045A/en
Publication of JP2006022045A publication Critical patent/JP2006022045A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a method for isolating and purifying an optically active 1-t-butoxycarbonyl-3-aminopyrrolidine salt, by which the highly pure optically active 1-t-butoxycarbonyl-3-aminopyrrolidine salt can be obtained in a high yield and by which the production of the salt can simply and efficiently be performed in a commercial scale. <P>SOLUTION: This method for isolating and purifying the optically active 1-t-butoxycarbonyl-3-aminopyrrolidine salt is characterized by forming a salt from the optically active 1-t-butoxycarbonyl-3-aminopyrrolidine and an acid, crystallizing the salt, and isolating the optically active 1-t-butoxycarbonyl-3-aminopyrrolidine salt as the crystals to leave contaminated impurities such as enantiomer and 1-t-butoxycarbonyl-3-t-butoxycarbonyl-aminopyrrolidine in the mother liquor. <P>COPYRIGHT: (C)2006,JPO&NCIPI

Description

本発明は、医薬中間体として有用な光学活性1−t−ブトキシカルボニル−3−アミノピロリジン塩の単離精製方法に関する。   The present invention relates to a method for isolating and purifying optically active 1-t-butoxycarbonyl-3-aminopyrrolidine salt useful as a pharmaceutical intermediate.

光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンの製造方法並びに単離精製方法としては、以下の方法が知られている。
(1)光学活性な3−アミノピロリジンの1位のアミノ基を選択的にt−ブトキシカルボニル化することにより、光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンを製造し、反応液の濃縮と析出した無機塩をろ別する操作を繰り返した後、ろ液濃縮物を蒸留することによって単離精製する方法(特許文献1)
(2)光学活性な3−アミノピロリジンの1位のアミノ基を選択的にt−ブトキシカルボニル化することにより、光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンを製造し、反応液から溶媒を留去し、酸性水溶液を添加して有機溶媒で洗浄した後、反応液を塩基性に調整して抽出、更に減圧濃縮する方法(特許文献2)
(3)光学活性な1−t−ブトキシカルボニル−3−(ベンジルオキシカルボニルアミノ)ピロリジンをパラジウム触媒存在下に加水素分解した後、触媒をろ別し、ろ液を濃縮後、シリカゲルカラムクロマトグラフィーにて精製、単離する方法(特許文献3)
(4)光学活性な1−t−ブトキシカルボニル−3−(トリフルオロアセチルアミノ)ピロリジンを水酸化リチウムで加水分解した後に中和し、反応液を濃縮する方法(非特許文献1)
(5)光学活性な1−t−ブトキシカルボニル−3−メタンスルホニルオキシピロリジンをアンモニアと反応させた後に、反応液に塩化メチレンを加えて析出する塩をろ別し、ろ液を濃縮する方法(特許文献4)
しかしながら、従来技術(1)では蒸留する前に煩雑な濃縮とろ過操作を繰り返す必要があり、従来技術(2)、(4)、(5)では抽出やろ過操作により無機塩等を除去するだけで、高い精製効果は期待できない。従来技術(3)では高価で煩雑なシリカゲルカラムクロマトグラフィーにて精製を行っており、商業的規模での実施が困難である。更に、これらの方法に共通することは光学異性体が混入した場合に、全く精製できないことが大きな課題である。
The following methods are known as methods for producing and isolating and purifying optically active 1-t-butoxycarbonyl-3-aminopyrrolidine.
(1) Optically active 1-t-butoxycarbonyl-3-aminopyrrolidine is produced by selectively t-butoxycarbonylating the amino group at position 1 of optically active 3-aminopyrrolidine. A method of isolating and purifying the filtrate concentrate by distillation after repeating the operation of concentration and filtering off the precipitated inorganic salt (Patent Document 1)
(2) Optically active 1-t-butoxycarbonyl-3-aminopyrrolidine is produced by selectively t-butoxycarbonylating the amino group at the 1-position of optically active 3-aminopyrrolidine. A method of distilling off the solvent, adding an acidic aqueous solution and washing with an organic solvent, adjusting the reaction solution to basic, extracting, and further concentrating under reduced pressure (Patent Document 2)
(3) Hydrogenolysis of optically active 1-t-butoxycarbonyl-3- (benzyloxycarbonylamino) pyrrolidine in the presence of a palladium catalyst, the catalyst is filtered off, the filtrate is concentrated, and silica gel column chromatography is performed. (PTL 3)
(4) A method in which optically active 1-t-butoxycarbonyl-3- (trifluoroacetylamino) pyrrolidine is hydrolyzed with lithium hydroxide and then neutralized, and the reaction solution is concentrated (Non-patent Document 1).
(5) A method in which optically active 1-t-butoxycarbonyl-3-methanesulfonyloxypyrrolidine is reacted with ammonia, methylene chloride is added to the reaction solution, the precipitated salt is filtered off, and the filtrate is concentrated ( Patent Document 4)
However, in the conventional technique (1), it is necessary to repeat complicated concentration and filtration operations before distillation, and in the conventional techniques (2), (4), and (5), only inorganic salts and the like are removed by extraction and filtration operations. Therefore, a high purification effect cannot be expected. In the prior art (3), purification is performed by expensive and complicated silica gel column chromatography, which is difficult to implement on a commercial scale. Furthermore, what is common to these methods is that it cannot be purified at all when optical isomers are mixed.

このような状況下において、医薬中間体として有用な前記化合物(1)の商業的規模での生産に適した単離精製方法は格別重要な意義を有しており、化学純度の向上だけでなく、同時に光学純度をも向上させることが可能な単離精製方法の確立が望まれる。
WO03/055858 特開2002−275155 WO04/013097 特開2000−53642 J.Med.Chem.2001、44、2933−2949
Under such circumstances, an isolation and purification method suitable for production on a commercial scale of the compound (1) useful as a pharmaceutical intermediate has a particularly important significance, not only for improving chemical purity. At the same time, it is desired to establish an isolation and purification method capable of improving the optical purity.
WO03 / 055858 JP 2002-275155 A WO04 / 013097 JP 2000-53642 A J. et al. Med. Chem. 2001, 44, 2933-2949

本発明は上記現状に鑑みて、高品質の光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンを高い収量で取得でき、簡便且つ効率的に商業的規模で実施できる単離精製方法を提供することが目的である。   In view of the above situation, the present invention provides an isolation and purification method capable of obtaining high-quality optically active 1-tert-butoxycarbonyl-3-aminopyrrolidine in a high yield and capable of being carried out easily and efficiently on a commercial scale. The purpose is to do.

本発明者らは1−t−ブトキシカルボニル−3−アミノピロリジンと酸から塩を形成させて、晶析することで、混入している不純物を効率的に除去出来ることを見出した。   The inventors of the present invention have found that a contaminated impurity can be efficiently removed by forming a salt from 1-t-butoxycarbonyl-3-aminopyrrolidine and an acid and crystallization.

即ち、本発明は、下記式(1);   That is, the present invention provides the following formula (1);

Figure 2006022045
(式中、*は不斉炭素原子を表す。)で表される光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンと酸から塩を形成させ、晶析することによって、混入している不純物を母液に残し、該塩を結晶として取得することを特徴とする、光学活性な1−t−ブトキシカルボニル−3−アミノピロリジン塩の単離精製方法である。
Figure 2006022045
(In the formula, * represents an asymmetric carbon atom.) A salt is formed from an optically active 1-tert-butoxycarbonyl-3-aminopyrrolidine represented by the formula (1) and an acid, and is mixed by crystallization. A method for isolating and purifying an optically active 1-tert-butoxycarbonyl-3-aminopyrrolidine salt, wherein impurities are left in a mother liquor and the salt is obtained as crystals.

本発明によれば、高品質の光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンを高い収量で取得でき、簡便且つ効率的に商業的規模で1−t−ブトキシカルボニル−3−アミノピロリジンの単離精製を実施することが可能である。   According to the present invention, high-quality optically active 1-t-butoxycarbonyl-3-aminopyrrolidine can be obtained in high yield, and 1-t-butoxycarbonyl-3-aminopyrrolidine can be obtained easily and efficiently on a commercial scale. Can be isolated and purified.

以下に、本発明を詳細に説明する。   The present invention is described in detail below.

本発明で用いる光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンは下記式(1);   The optically active 1-t-butoxycarbonyl-3-aminopyrrolidine used in the present invention is represented by the following formula (1);

Figure 2006022045
で表される。式中、*は不斉炭素原子を表す。前記化合物(1)は例えば、特開2000−53642や特表平07−506110に記載の方法にて得られた光学活性な1−ベンジル−3−アミノピロリジンのベンジル基を脱保護することにより、光学活性3−アミノピロリジンを取得し、これをWO03/055858や特開2002−275155に記載の方法にて1位のアミノ基を選択的にt−ブトキシカルボニル化することにより、簡便に製造することができる。
Figure 2006022045
It is represented by In the formula, * represents an asymmetric carbon atom. The compound (1) can be obtained by, for example, deprotecting the benzyl group of optically active 1-benzyl-3-aminopyrrolidine obtained by the method described in JP-A-2000-53642 or JP-T-07-506110. An optically active 3-aminopyrrolidine is obtained, which is easily produced by selectively t-butoxycarbonylating the amino group at the 1-position by the method described in WO03 / 055858 or JP-A-2002-275155. Can do.

本発明で用いる光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンは、製造方法により、種々の不純物を含有するが、不純物としては例えば、光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンのエナンチオマーや、下記式(2);   The optically active 1-tert-butoxycarbonyl-3-aminopyrrolidine used in the present invention contains various impurities depending on the production method. Examples of the impurities include optically active 1-tert-butoxycarbonyl-3-amino. Pyrrolidine enantiomer, and the following formula (2);

Figure 2006022045
(式中、*は前記に同じ)で表される光学活性な1−t−ブトキシカルボニル−3−t−ブトキシカルボニルアミノピロリジンなどが考えられる。
Figure 2006022045
An optically active 1-t-butoxycarbonyl-3-t-butoxycarbonylaminopyrrolidine represented by the formula (wherein * is the same as above) can be considered.

上記WO03/055858や特開2002−275155記載の方法で製造した場合、前記化合物(2)が、不純物として混入することが知られている。また、特開2000−53642に記載の方法では、光学活性な1−t−ブトキシカルボニル−3−(メタンスルホニルオキシ)ピロリジンをアンモニアでアミノ化することにより前記化合物(1)を製造しているが、この方法で得られる前記化合物(1)にはエナンチオマー(鏡像異性体)が一部混入するため、低光学純度のものしか得ることができない。   It is known that the compound (2) is mixed as an impurity when manufactured by the method described in WO03 / 055858 or JP-A-2002-275155. Further, in the method described in JP-A-2000-53642, the compound (1) is produced by amination of optically active 1-t-butoxycarbonyl-3- (methanesulfonyloxy) pyrrolidine with ammonia. Since the compound (1) obtained by this method is partially mixed with enantiomers (enantiomers), only those having low optical purity can be obtained.

一般に、構造の類似した不純物(類縁物質)の除去は難しく、前記不純物群を除去して高品質の目的物を得るためには、優れた単離精製方法を開発する必要があった。本発明者らは鋭意検討の結果、前記化合物(1)と酸から塩を形成させ、晶析することによって混入している不純物、なかでも、前記化合物(1)のエナンチオマーや、前記化合物(2)を母液に残し、該塩を結晶として取得することにより、光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンを塩として単離する方法を開発するに至った。   In general, it is difficult to remove impurities (analogous substances) having a similar structure, and it has been necessary to develop an excellent isolation and purification method in order to obtain the high-quality target product by removing the impurity group. As a result of intensive studies, the inventors of the present invention have formed a salt from the compound (1) and an acid, and crystallized to cause impurities, especially the enantiomer of the compound (1) and the compound (2). ) Was left in the mother liquor and the salt was obtained as crystals, leading to the development of a method for isolating optically active 1-tert-butoxycarbonyl-3-aminopyrrolidine as a salt.

本発明で使用する酸としては、光学活性な酸と非光学活性な酸に分けられ、光学活性な酸としては例えば、カンファースルホン酸等のスルホン酸;リンゴ酸、マンデル酸、酒石酸等のカルボン酸;N−(ベンゼンスルホニル)フェニルアラニン等の窒素上が保護されたアミノ酸が挙げられる。好ましくは安価に入手可能な非光学活性な酸であり、例えば、塩化水素、臭化水素、りん酸、硫酸等の鉱酸;メタンスルホン酸、p−トルエンスルホン酸等のスルホン酸;酢酸、シュウ酸等のカルボン酸等が挙げられる。その中で高収量且つ得られる結晶の吸湿性が低いなどの観点から、塩化水素、臭化水素、メタンスルホン酸、又は酢酸が好ましく、更に結晶のろ過性が良い等の観点から、塩化水素、又は酢酸が特に好ましい。これらの酸は、単独または2種以上を併用して用いることもできる。これら酸としては例えば、取り扱いが容易な塩酸や臭化水素酸のような酸水溶液を使用しても良い。   The acid used in the present invention is classified into an optically active acid and a non-optically active acid. Examples of the optically active acid include sulfonic acids such as camphorsulfonic acid; carboxylic acids such as malic acid, mandelic acid, and tartaric acid. A nitrogen-protected amino acid such as N- (benzenesulfonyl) phenylalanine; Preferably, it is a non-optically active acid which can be obtained at low cost, for example, mineral acids such as hydrogen chloride, hydrogen bromide, phosphoric acid and sulfuric acid; sulfonic acids such as methanesulfonic acid and p-toluenesulfonic acid; Examples thereof include carboxylic acids such as acids. Among them, hydrogen chloride, hydrogen bromide, methanesulfonic acid, or acetic acid is preferable from the viewpoint of high yield and low hygroscopicity of the obtained crystal, and from the viewpoint of good crystal filterability, hydrogen chloride, Or acetic acid is particularly preferred. These acids can be used alone or in combination of two or more. As these acids, for example, acid aqueous solutions such as hydrochloric acid and hydrobromic acid which are easy to handle may be used.

前記酸の使用量は特に限定されないが、前記式(1)で表される光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンと塩を形成させ、結晶として析出させることができる量を使用すれば良く、収率良く、優れた精製効果を得るという観点から、前記式(1)で表される光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンに対して、好ましくは0.1〜3倍モル量、より好ましくは0.5〜1.5倍モル量、更に好ましくは0.8〜1.2倍モル量を用いるとよい。   The amount of the acid used is not particularly limited, but an amount that can form a salt with the optically active 1-tert-butoxycarbonyl-3-aminopyrrolidine represented by the formula (1) and precipitate as crystals is used. From the viewpoint of obtaining an excellent purification effect with a good yield, the optically active 1-tert-butoxycarbonyl-3-aminopyrrolidine represented by the formula (1) is preferably 0.1. -3 times molar amount, more preferably 0.5-1.5 times molar amount, and still more preferably 0.8-1.2 times molar amount.

本発明の単離精製方法は溶媒中で好ましく実施される。本発明で使用することのできる溶媒は有機溶媒であり、例えば、イソプロパノール、エタノール、メタノール等のアルコール類;エチレングリコール、プロピレングリコール等の多価アルコール類;酢酸エチル、酢酸メチル等の脂肪酸エステル類;トルエン、ヘキサン等の炭化水素類;ジエチルエーテル、テトラヒドロフラン、メチルt−ブチルエーテル等のエーテル類;グライム等のポリエーテル類;塩化メチレン等のハロゲン化炭化水素類;ジメチルホルムアミド等のアミド類;ジメチルスルホキシド等のスルホキシド類を挙げることができる。好ましくは、脂肪酸エステル類、炭化水素類、アルコール類であり、更に好ましくは、酢酸エチル、トルエン、ヘキサン、イソプロパノール、エタノールである。これらの溶媒は、単独で用いても2種以上を併用しても良い。また、これら溶媒の種類、使用量、混合比は、取得する塩の溶解度に合わせて適宜選択すれば良い。   The isolation and purification method of the present invention is preferably carried out in a solvent. The solvent that can be used in the present invention is an organic solvent, for example, alcohols such as isopropanol, ethanol, and methanol; polyhydric alcohols such as ethylene glycol and propylene glycol; fatty acid esters such as ethyl acetate and methyl acetate; Hydrocarbons such as toluene and hexane; Ethers such as diethyl ether, tetrahydrofuran and methyl t-butyl ether; Polyethers such as glyme; Halogenated hydrocarbons such as methylene chloride; Amides such as dimethylformamide; Dimethyl sulfoxide and the like The sulfoxides can be mentioned. Preferred are fatty acid esters, hydrocarbons, and alcohols, and more preferred are ethyl acetate, toluene, hexane, isopropanol, and ethanol. These solvents may be used alone or in combination of two or more. Moreover, what is necessary is just to select suitably the kind, usage-amount, and mixing ratio of these solvents according to the solubility of the salt to acquire.

次に、前記式(1)で表される光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンと酸から形成された塩の結晶化方法としては特に限定されないが、例えば以下のような方法が挙げられる。
(a)光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンと酸の水溶液を混合した後、濃縮して水分を留去することにより結晶化させる方法。この場合、水と共沸しうる溶媒(例えば、酢酸エチル、トルエン等)を使用し、共沸効果により水分をより効率的に留去することもできる。
(b)光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンを溶媒中で酸と混合することにより結晶化させる方法。
(c)光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンと酸を溶媒中で混合するか、又は、1−t−ブトキシカルボニル−3−アミノピロリジン塩を溶媒に溶解させた後、冷却して結晶化させる方法。
(d)光学活性な1−t−ブトキシカルボニル−3−アミノピロリジン塩を溶媒に溶解させた後、貧溶媒を添加または貧溶媒に濃縮置換することにより結晶化させる方法。
Next, the method for crystallizing the salt formed from the optically active 1-t-butoxycarbonyl-3-aminopyrrolidine represented by the formula (1) and an acid is not particularly limited. Is mentioned.
(A) A method in which an optically active 1-t-butoxycarbonyl-3-aminopyrrolidine and an aqueous solution of an acid are mixed and then concentrated to distill off water to cause crystallization. In this case, a solvent that can azeotrope with water (for example, ethyl acetate, toluene, etc.) can be used, and water can be more efficiently distilled off due to the azeotropic effect.
(B) A method of crystallizing optically active 1-t-butoxycarbonyl-3-aminopyrrolidine by mixing with an acid in a solvent.
(C) Optically active 1-t-butoxycarbonyl-3-aminopyrrolidine and an acid are mixed in a solvent, or 1-t-butoxycarbonyl-3-aminopyrrolidine salt is dissolved in a solvent and then cooled. And crystallizing.
(D) A method in which an optically active 1-t-butoxycarbonyl-3-aminopyrrolidine salt is dissolved in a solvent, and then crystallized by adding a poor solvent or concentrating to the poor solvent.

前記の結晶化方法は、酸の種類と溶媒の組み合わせにより、適切に選択すれば良い。例えば、塩化水素、又は臭化水素はその水溶液である塩酸、又は臭化水素酸で取り扱う方が容易であるため、(a)の方法が適しており、また、メタンスルホン酸、酢酸等の通常非含水物として使用し易い酸を用いる場合は、(b)の方法を選択するのが好ましい。更に、(a)又は(b)の方法で得たれた塩の懸濁溶液を、(c)の方法にて再溶解した後、冷却して結晶化させる等、(a)、(b)、(c)、(d)の方法を適宜組み合わせて結晶化させることもできる。   The crystallization method may be appropriately selected depending on the combination of the acid type and the solvent. For example, since hydrogen chloride or hydrogen bromide is easier to handle with hydrochloric acid or hydrobromic acid which is an aqueous solution thereof, the method (a) is suitable, and methanesulfonic acid, acetic acid and the like are usually used. In the case of using an acid that is easy to use as a non-hydrous material, it is preferable to select the method (b). Furthermore, the salt suspension obtained by the method (a) or (b) is re-dissolved by the method (c) and then cooled and crystallized, etc. (a), (b), Crystallization can also be performed by appropriately combining the methods (c) and (d).

前記結晶化方法で用いる溶媒としては、前述の溶媒と同じものが挙げられ、(d)の方法で用いる貧溶媒としては、例えば、トルエン、ヘキサン等が挙げられる。   Examples of the solvent used in the crystallization method include the same solvents as those described above, and examples of the poor solvent used in the method (d) include toluene and hexane.

前記(c)、(d)の方法における光学活性な1−t−ブトキシカルボニル−3−アミノピロリジン塩としては例えば、前記(a)、(b)の方法により一旦取得した光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンと酸から形成された塩を使用してもよいし、光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンを製造する際に酸を共存させることにより生成される、光学活性な1−t−ブトキシカルボニル−3−アミノピロリジン塩を使用してもよい。   Examples of the optically active 1-t-butoxycarbonyl-3-aminopyrrolidine salt in the methods (c) and (d) include the optically active 1-t once obtained by the methods (a) and (b). -Butoxycarbonyl-3-aminopyrrolidine and a salt formed from an acid may be used, and it is produced by coexisting an acid in producing optically active 1-tert-butoxycarbonyl-3-aminopyrrolidine. Alternatively, an optically active 1-t-butoxycarbonyl-3-aminopyrrolidine salt may be used.

また、光学活性な1−t−ブトキシカルボニル−3−アミノピロリジン塩を溶媒に溶解させる際に、例えば加熱等を行うこともできる。その場合の加熱温度は特に限定されないが、使用する溶媒種又は混合溶媒種に光学活性な1−t−ブトキシカルボニル−3−アミノピロリジン塩が溶解する温度以上で適切に設定すればよい。また、結晶化の際には種晶を加えてもよい。   In addition, when the optically active 1-t-butoxycarbonyl-3-aminopyrrolidine salt is dissolved in a solvent, for example, heating or the like can be performed. The heating temperature in that case is not particularly limited, but may be appropriately set at a temperature equal to or higher than the temperature at which the optically active 1-tert-butoxycarbonyl-3-aminopyrrolidine salt is dissolved in the solvent species or mixed solvent species to be used. In addition, seed crystals may be added during crystallization.

前記(a)〜(d)の結晶化方法における実施温度は、特に限定されないが、塩の種類と使用する溶媒の種類により適宜選択すればよく、好ましくは使用する溶媒種又は混合溶媒種に光学活性な1−t−ブトキシカルボニル−3−アミノピロリジン塩が溶解する温度未満で、目標とする析出量と結晶の品質に応じて設定すればよい。   The implementation temperature in the crystallization methods (a) to (d) is not particularly limited, but may be appropriately selected depending on the type of salt and the type of solvent used. What is necessary is just to set according to the target precipitation amount and the quality of a crystal | crystallization below the temperature which active 1-t-butoxycarbonyl-3-aminopyrrolidine salt melt | dissolves.

前記(a)〜(d)の結晶化方法により、析出した光学活性な1−t−ブトキシカルボニル−3−アミノピロリジン塩の結晶は、減圧ろ過、加圧ろ過又は遠心分離等の方法により分離、取得することができる。また、取得結晶中に母液が残存して結晶の純度が低下する場合は、必要に応じ、更に溶媒で洗浄することにより品質を高めることもできる。
結晶の乾燥方法としては、熱分解や溶融を避けて約60℃以下で、減圧乾燥(真空乾燥)するのが望ましい。
The crystals of the optically active 1-t-butoxycarbonyl-3-aminopyrrolidine salt precipitated by the crystallization methods (a) to (d) are separated by a method such as vacuum filtration, pressure filtration, or centrifugation, Can be acquired. Further, when the mother liquor remains in the acquired crystal and the purity of the crystal is lowered, the quality can be improved by further washing with a solvent, if necessary.
As a method for drying the crystals, it is desirable to dry under reduced pressure (vacuum drying) at about 60 ° C. or less while avoiding thermal decomposition and melting.

前記方法によって取得した光学活性な1−t−ブトキシカルボニル−3−アミノピロリジン塩は、化学純度と共に、光学純度も向上しており、そのまま医薬中間体の原料として用いることもできるが、更に水酸化アルカリ金属等の塩基で処理することにより、前記式(1)で表される光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンを遊離させ、抽出、濃縮等の操作を行うことにより、化学純度及び光学純度の向上した前記化合物(1)を取得することもできる。   The optically active 1-tert-butoxycarbonyl-3-aminopyrrolidine salt obtained by the above method has improved chemical purity as well as optical purity, and can be used as a raw material for a pharmaceutical intermediate as it is. By treating with a base such as an alkali metal, the optically active 1-tert-butoxycarbonyl-3-aminopyrrolidine represented by the above formula (1) is liberated, and operations such as extraction, concentration, etc. are carried out. The compound (1) having improved purity and optical purity can also be obtained.

以下に、実施例を挙げて本発明を更に詳しく説明するが、本発明はこれら実施例のみに限定されるものではない。     Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples.

尚、以下の実施例における光学純度は、下記方法により決定した。1−t−ブトキシカルボニル−3−アミノピロリジンの塩約10mgとイソプロパノール2ml、トリエチルアミン100mgを混合した後に、二炭酸ジベンジル15mgを加えて約30秒間攪拌、これにヘキサン20mlを加えて試料溶液とした。5μLをHPLCに注入してその面積比から光学純度を算出した。分析カラムにはCHIRALPACK OD−H(ダイセル)4.6mmΦ×250mmを用いた。移動相にはヘキサン/イソプロパノール(95/5(容積比))を用い、流速は1.0mL/分で、カラム温度30℃、検出はUV254nmで行った。(S)−1−t−ブトキシカルボニル−3−ベンジルオキシカルボニルアミノピロリジンの保持時間は16.0分、(R)−1−t−ブトキシカルボニル−3−ベンジルオキシカルボニルアミノピロリジンの保持時間は12.8分であった。   The optical purity in the following examples was determined by the following method. After mixing about 10 mg of 1-t-butoxycarbonyl-3-aminopyrrolidine salt with 2 ml of isopropanol and 100 mg of triethylamine, 15 mg of dibenzyl dicarbonate was added and stirred for about 30 seconds, and 20 ml of hexane was added thereto to prepare a sample solution. 5 μL was injected into the HPLC, and the optical purity was calculated from the area ratio. CHIRALPACK OD-H (Daicel) 4.6 mmΦ × 250 mm was used for the analytical column. Hexane / isopropanol (95/5 (volume ratio)) was used as the mobile phase, the flow rate was 1.0 mL / min, the column temperature was 30 ° C., and the detection was performed at UV254 nm. The retention time of (S) -1-t-butoxycarbonyl-3-benzyloxycarbonylaminopyrrolidine is 16.0 minutes, and the retention time of (R) -1-t-butoxycarbonyl-3-benzyloxycarbonylaminopyrrolidine is 12. 8 minutes.

(参考例1)
東京化成工業(株)より販売されている3−トリフルオロアセチルアミノピロリジン塩酸塩20.8g、N,N−ジイソプロピルエチルアミン18.2ml、塩化メチレン250mlを混合した後に、二炭酸ジ−t−ブチル20.8gの塩化メチレン(25ml)溶液をゆっくりと添加した。室温で2時間攪拌した後に、飽和炭酸ナトリウム水溶液300ml、塩化メチレン500mlを加え、抽出した。水層を塩化メチレン500mlで抽出し、有機層を混合して、減圧下にて溶媒を留去した。残渣を減圧蒸留することにより、1−t−ブトキシカルボニル−3−アミノピロリジン12.2g得た。このものは化学純度98.2重量%、光学純度89.5%ee.(S体過剰)であった。
(Reference Example 1)
After mixing 20.8 g of 3-trifluoroacetylaminopyrrolidine hydrochloride sold by Tokyo Chemical Industry Co., Ltd., 18.2 ml of N, N-diisopropylethylamine and 250 ml of methylene chloride, di-t-butyl dicarbonate 20 .8 g of methylene chloride (25 ml) solution was added slowly. After stirring at room temperature for 2 hours, 300 ml of saturated aqueous sodium carbonate solution and 500 ml of methylene chloride were added for extraction. The aqueous layer was extracted with 500 ml of methylene chloride, the organic layers were mixed, and the solvent was distilled off under reduced pressure. The residue was distilled under reduced pressure to obtain 12.2 g of 1-t-butoxycarbonyl-3-aminopyrrolidine. This had a chemical purity of 98.2% by weight and an optical purity of 89.5% ee. (S body excess).

(実施例1)
化学純度98.2重量%、光学純度89.5%ee(S体過剰)の1−t−ブトキシカルボニル−3−アミノピロリジン0.50gを酢酸エチル5mLに溶解させた。ここに、濃塩酸0.28g(1−t−ブトキシカルボニル−3−アミノピロリジンに対して1.0モル当量)を加えた。この溶液を減圧濃縮し、濃縮物に酢酸エチル15mLを加えて再度濃縮した。得られた濃縮物に酢酸エチル5mLを加えると結晶が析出し、室温で1時間攪拌後、結晶を減圧ろ別し、真空乾燥することにより、1−t−ブトキシカルボニル−3−アミノピロリジンの塩酸塩を0.43g得た。光学純度は98.3%eeまで向上していた。
Example 1
0.50 g of 1-t-butoxycarbonyl-3-aminopyrrolidine having a chemical purity of 98.2% by weight and an optical purity of 89.5% ee (S-form excess) was dissolved in 5 mL of ethyl acetate. To this, 0.28 g of concentrated hydrochloric acid (1.0 molar equivalent relative to 1-t-butoxycarbonyl-3-aminopyrrolidine) was added. The solution was concentrated under reduced pressure, 15 mL of ethyl acetate was added to the concentrate, and the mixture was concentrated again. When 5 mL of ethyl acetate is added to the resulting concentrate, crystals are precipitated. After stirring at room temperature for 1 hour, the crystals are filtered under reduced pressure and dried under vacuum to give hydrochloric acid of 1-tert-butoxycarbonyl-3-aminopyrrolidine. 0.43 g of salt was obtained. The optical purity was improved to 98.3% ee.

(実施例2)
化学純度98.2重量%、光学純度89.5%ee(S体過剰)の1−t−ブトキシカルボニル−3−アミノピロリジン0.50gを酢酸エチル5mLに溶解させた。ここに、酢酸0.16g(1−t−ブトキシカルボニル−3−アミノピロリジンに対して1.0モル当量)を加えた。この溶液を減圧濃縮し、濃縮物にヘキサン20mLを加えると結晶が析出した。室温で1時間攪拌後、結晶を減圧ろ別し、真空乾燥することにより、1−t−ブトキシカルボニル−3−アミノピロリジンの酢酸塩を0.57g得た。光学純度は93.0%eeまで向上していた。
(Example 2)
0.50 g of 1-t-butoxycarbonyl-3-aminopyrrolidine having a chemical purity of 98.2% by weight and an optical purity of 89.5% ee (S-form excess) was dissolved in 5 mL of ethyl acetate. To this, 0.16 g of acetic acid (1.0 molar equivalent relative to 1-t-butoxycarbonyl-3-aminopyrrolidine) was added. This solution was concentrated under reduced pressure, and 20 mL of hexane was added to the concentrate to precipitate crystals. After stirring at room temperature for 1 hour, the crystals were filtered off under reduced pressure and vacuum-dried to obtain 0.57 g of 1-t-butoxycarbonyl-3-aminopyrrolidine acetate. The optical purity was improved to 93.0% ee.

(実施例3)
化学純度98.2重量%、光学純度89.5%ee(S体過剰)の1−t−ブトキシカルボニル−3−アミノピロリジン0.50gをエタノール5mLに溶解させた。これにメタンスルホン酸0.26g(1−t−ブトキシカルボニル−3−アミノピロリジンに対して1.0モル当量)を添加した。この溶液を減圧濃縮し、濃縮物に酢酸エチル10mLを加えると結晶が析出した。室温で1時間攪拌後、結晶を減圧ろ別し、真空乾燥することにより、1−t−ブトキシカルボニル−3−アミノピロリジンのメタンスルホン酸塩を0.66g得た。光学純度は91.1%eeまで向上していた。
Example 3
0.50 g of 1-t-butoxycarbonyl-3-aminopyrrolidine having a chemical purity of 98.2% by weight and an optical purity of 89.5% ee (S-form excess) was dissolved in 5 mL of ethanol. To this was added 0.26 g of methanesulfonic acid (1.0 molar equivalent based on 1-t-butoxycarbonyl-3-aminopyrrolidine). The solution was concentrated under reduced pressure, and 10 mL of ethyl acetate was added to the concentrate to precipitate crystals. After stirring at room temperature for 1 hour, the crystals were filtered off under reduced pressure and vacuum dried to obtain 0.66 g of 1-t-butoxycarbonyl-3-aminopyrrolidine methanesulfonate. The optical purity was improved to 91.1% ee.

(実施例4)
化学純度98.2重量%、光学純度89.5%ee(S体過剰)の1−t−ブトキシカルボニル−3−アミノピロリジン0.50gをエタノール5mLに溶解させた。これに塩酸0.28g(1−t−ブトキシカルボニル−3−アミノピロリジンに対して1.0モル当量)を添加した。この溶液を減圧濃縮し、濃縮物にエタノール15mLを加えて再度濃縮し、得られた濃縮物に酢酸エチル10mLを加えると結晶が析出した。室温で1時間攪拌後、結晶を減圧ろ別、真空乾燥することにより、1−t−ブトキシカルボニル−3−アミノピロリジンの塩酸塩を0.42g得た。光学純度は96.9%eeまで向上していた。
Example 4
0.50 g of 1-t-butoxycarbonyl-3-aminopyrrolidine having a chemical purity of 98.2% by weight and an optical purity of 89.5% ee (S-form excess) was dissolved in 5 mL of ethanol. To this was added 0.28 g of hydrochloric acid (1.0 molar equivalent with respect to 1-t-butoxycarbonyl-3-aminopyrrolidine). This solution was concentrated under reduced pressure, 15 mL of ethanol was added to the concentrate, and the mixture was concentrated again. When 10 mL of ethyl acetate was added to the resulting concentrate, crystals were precipitated. After stirring at room temperature for 1 hour, the crystals were filtered off under reduced pressure and vacuum dried to obtain 0.42 g of 1-t-butoxycarbonyl-3-aminopyrrolidine hydrochloride. The optical purity was improved to 96.9% ee.

(実施例5)
化学純度98.2重量%、光学純度89.5%ee(S体過剰)の1−t−ブトキシカルボニル−3−アミノピロリジン0.50gを酢酸エチル5mLに溶解させた。これに酢酸0.14g(1−t−ブトキシカルボニル−3−アミノピロリジンに対して0.9モル当量)を添加した。この溶液にヘキサン25mLを加えると結晶が析出し、室温で1時間攪拌後、結晶を減圧ろ別し、真空乾燥することにより、1−t−ブトキシカルボニル−3−アミノピロリジンの酢酸塩を0.55g得た。光学純度は94.6%eeまで向上していた。
(Example 5)
0.50 g of 1-t-butoxycarbonyl-3-aminopyrrolidine having a chemical purity of 98.2% by weight and an optical purity of 89.5% ee (S-form excess) was dissolved in 5 mL of ethyl acetate. To this was added 0.14 g of acetic acid (0.9 molar equivalents relative to 1-t-butoxycarbonyl-3-aminopyrrolidine). When 25 mL of hexane is added to this solution, crystals are precipitated. After stirring at room temperature for 1 hour, the crystals are filtered off under reduced pressure and dried under vacuum to give 1-tert-butoxycarbonyl-3-aminopyrrolidine acetate as a salt. 55 g was obtained. The optical purity was improved to 94.6% ee.

(実施例6)
化学純度98.2重量%、光学純度89.5%ee(S体過剰)の1−t−ブトキシカルボニル−3−アミノピロリジン0.50gを酢酸エチル10mLに溶解させた。これに酢酸0.14g(1−t−ブトキシカルボニル−3−アミノピロリジンに対して0.9モル当量)を添加した。この溶液にヘキサン15mLを加えると結晶が析出した。これを50℃に加温して結晶を溶解させた後に、5℃まで徐々に冷却することにより、結晶が析出した。1時間攪拌後、結晶を減圧ろ別し、真空乾燥することにより、1−t−ブトキシカルボニル−3−アミノピロリジンの酢酸塩を0.57g得た。光学純度は91.6%eeまで向上していた。
(Example 6)
0.50 g of 1-t-butoxycarbonyl-3-aminopyrrolidine having a chemical purity of 98.2% by weight and an optical purity of 89.5% ee (S-form excess) was dissolved in 10 mL of ethyl acetate. To this was added 0.14 g of acetic acid (0.9 molar equivalents relative to 1-t-butoxycarbonyl-3-aminopyrrolidine). When 15 mL of hexane was added to this solution, crystals were precipitated. This was heated to 50 ° C. to dissolve the crystals, and then gradually cooled to 5 ° C. to precipitate crystals. After stirring for 1 hour, the crystals were filtered off under reduced pressure and dried under vacuum to obtain 0.57 g of 1-t-butoxycarbonyl-3-aminopyrrolidine acetate. The optical purity was improved to 91.6% ee.

(実施例7)
化学純度81.8重量%(1−t−ブトキシカルボニル−3−t−ブトキシカルボニルアミノピロリジンを16.8重量%含有)、光学純度89.5%ee(S体過剰)の1−t−ブトキシカルボニル−3−アミノピロリジン0.60gを酢酸エチル5mLに溶解させた。これに酢酸0.14g(1−t−ブトキシカルボニル−3−アミノピロリジンに対して0.9モル当量)を添加した。この溶液にヘキサン15mLを加えると結晶が析出した。室温で1時間攪拌後、結晶を減圧ろ別した。得られた結晶に、酢酸エチル10mL、水2mL、30%水酸化ナトリウム水溶液0.53gを加え、水層を除去した。有機層を減圧濃縮することにより、1−t−ブトキシカルボニル−3−アミノピロリジンを0.35g取得した。化学純度は98.6重量%、1−t−ブトキシカルボニル−3−t−ブトキシカルボニル−アミノピロリジンは完全に除去されており、光学純度は96.9%eeまで向上していた。
(Example 7)
1-t-butoxy having a chemical purity of 81.8% by weight (containing 16.8% by weight of 1-t-butoxycarbonyl-3-t-butoxycarbonylaminopyrrolidine) and optical purity of 89.5% ee (S-form excess) 0.60 g of carbonyl-3-aminopyrrolidine was dissolved in 5 mL of ethyl acetate. To this was added 0.14 g of acetic acid (0.9 molar equivalents relative to 1-t-butoxycarbonyl-3-aminopyrrolidine). When 15 mL of hexane was added to this solution, crystals were precipitated. After stirring at room temperature for 1 hour, the crystals were filtered off under reduced pressure. To the obtained crystals, 10 mL of ethyl acetate, 2 mL of water, and 0.53 g of 30% aqueous sodium hydroxide solution were added, and the aqueous layer was removed. The organic layer was concentrated under reduced pressure to obtain 0.35 g of 1-t-butoxycarbonyl-3-aminopyrrolidine. The chemical purity was 98.6% by weight, 1-t-butoxycarbonyl-3-t-butoxycarbonyl-aminopyrrolidine was completely removed, and the optical purity was improved to 96.9% ee.

(実施例8)
化学純度80.2重量%、光学純度96.6%eeの1−t−ブトキシカルボニル−3−アミノピロリジン0.46gをイソプロパノール4mLに溶解させ、濃塩酸0.21g(1−t−ブトキシカルボニル−3−アミノピロリジンに対して1.0モル当量)を添加し、減圧濃縮した。濃縮物に酢酸エチル8mLを添加すると結晶が析出し、25℃で10分攪拌した後に、結晶を減圧ろ別し、真空乾燥することにより、1−t−ブトキシカルボニル−3−アミノピロリジンの塩酸塩を0.41g得た。光学純度は99.0%eeまで向上していた。この結晶0.35gをイソプロパノール2mLに溶解させた後に減圧濃縮し、濃縮物に酢酸エチル8mLを添加すると結晶が析出し、25℃で10分攪拌した後に、結晶を減圧ろ別し、酢酸エチル2mLにて湿結晶を洗浄した。これを真空乾燥することにより、1−t−ブトキシカルボニル−3−アミノピロリジンの塩酸塩を0.34g得た。光学純度は99.7%eeまで向上していた。
(Example 8)
0.46 g of 1-t-butoxycarbonyl-3-aminopyrrolidine having a chemical purity of 80.2 wt% and an optical purity of 96.6% ee was dissolved in 4 mL of isopropanol, and 0.21 g of concentrated hydrochloric acid (1-t-butoxycarbonyl- 1.0 molar equivalents relative to 3-aminopyrrolidine) was added and concentrated under reduced pressure. When 8 mL of ethyl acetate was added to the concentrate, crystals precipitated. After stirring at 25 ° C. for 10 minutes, the crystals were filtered under reduced pressure and dried under vacuum to give hydrochloride of 1-t-butoxycarbonyl-3-aminopyrrolidine. 0.41 g was obtained. The optical purity was improved to 99.0% ee. 0.35 g of this crystal was dissolved in 2 mL of isopropanol and concentrated under reduced pressure. When 8 mL of ethyl acetate was added to the concentrate, the crystal was precipitated, and stirred at 25 ° C. for 10 minutes. The wet crystals were washed with This was vacuum-dried to obtain 0.34 g of 1-t-butoxycarbonyl-3-aminopyrrolidine hydrochloride. The optical purity was improved to 99.7% ee.

Claims (5)

下記式(1);
Figure 2006022045
(式中、*は不斉炭素原子を表す。)で表される光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンと酸から塩を形成させ、晶析することによって、混入している不純物を母液に残し、該塩を結晶として取得することを特徴とする、光学活性な1−t−ブトキシカルボニル−3−アミノピロリジン塩の単離精製方法。
Following formula (1);
Figure 2006022045
(In the formula, * represents an asymmetric carbon atom.) A salt is formed from an optically active 1-tert-butoxycarbonyl-3-aminopyrrolidine represented by the formula (1) and an acid, and is mixed by crystallization. A method for isolating and purifying an optically active 1-tert-butoxycarbonyl-3-aminopyrrolidine salt, wherein impurities are left in a mother liquor and the salt is obtained as crystals.
前記酸が非光学活性な酸である、請求項1に記載の単離精製方法。   The isolation and purification method according to claim 1, wherein the acid is a non-optically active acid. 前記非光学活性な酸が、塩化水素、臭化水素、メタンスルホン酸、又は酢酸である、請求項2に記載の単離精製方法。   The isolation and purification method according to claim 2, wherein the non-optically active acid is hydrogen chloride, hydrogen bromide, methanesulfonic acid, or acetic acid. 前記非光学活性な酸が、塩化水素、又は酢酸である、請求項2に記載の単離精製方法。   The isolation and purification method according to claim 2, wherein the non-optically active acid is hydrogen chloride or acetic acid. 前記の混入している不純物が、前記式(1)で表される光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンのエナンチオマー、及び/又は、下記式(2);
Figure 2006022045
(式中、*は不斉炭素原子を表す。)で表される光学活性な1−t−ブトキシカルボニル−3−t−ブトキシカルボニルアミノピロリジンである、請求項1〜4のいずれかに記載の単離精製方法。
The contaminated impurity is an enantiomer of optically active 1-tert-butoxycarbonyl-3-aminopyrrolidine represented by the formula (1) and / or the following formula (2);
Figure 2006022045
(Wherein * represents an asymmetric carbon atom), which is an optically active 1-t-butoxycarbonyl-3-t-butoxycarbonylaminopyrrolidine represented by any one of claims 1 to 4. Isolation and purification method.
JP2004201784A 2004-07-08 2004-07-08 METHOD FOR ISOLATING AND PURIFYING OPTICALLY ACTIVE 1-t-BUTOXYCARBONYL-3-AMINOPYRROLIDINE SALT Pending JP2006022045A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004201784A JP2006022045A (en) 2004-07-08 2004-07-08 METHOD FOR ISOLATING AND PURIFYING OPTICALLY ACTIVE 1-t-BUTOXYCARBONYL-3-AMINOPYRROLIDINE SALT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004201784A JP2006022045A (en) 2004-07-08 2004-07-08 METHOD FOR ISOLATING AND PURIFYING OPTICALLY ACTIVE 1-t-BUTOXYCARBONYL-3-AMINOPYRROLIDINE SALT

Publications (1)

Publication Number Publication Date
JP2006022045A true JP2006022045A (en) 2006-01-26

Family

ID=35795583

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004201784A Pending JP2006022045A (en) 2004-07-08 2004-07-08 METHOD FOR ISOLATING AND PURIFYING OPTICALLY ACTIVE 1-t-BUTOXYCARBONYL-3-AMINOPYRROLIDINE SALT

Country Status (1)

Country Link
JP (1) JP2006022045A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007297306A (en) * 2006-04-28 2007-11-15 Kaneka Corp Method for producing optically active 3-(1-pyrrolidinyl)pyrrolidine
JP2012110373A (en) * 2010-11-19 2012-06-14 Canon Inc Image processing apparatus and image processing method

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000514801A (en) * 1996-07-08 2000-11-07 ローヌ―プーラン ローラー ファーマシューティカルズ インコーポレイテッド Compounds with anti-hypertensive, cardioprotective, anti-ischemic and anti-lipolytic properties
WO2001030745A1 (en) * 1999-10-25 2001-05-03 Fujisawa Pharmaceutical Co., Ltd. Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
JP2002275155A (en) * 2001-01-11 2002-09-25 Sankyo Co Ltd Method for producing cyclic amine derivative
WO2003055858A1 (en) * 2001-12-27 2003-07-10 Toray Fine Chemicals Co., Ltd. Process for producing 1-alkoxycarbonyl nitrogenous saturated heterocyclic derivative
WO2004013097A1 (en) * 2002-08-01 2004-02-12 Basilea Pharmaceutica Ag Process for the preparation of amino-pyrrolidine derivatives

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000514801A (en) * 1996-07-08 2000-11-07 ローヌ―プーラン ローラー ファーマシューティカルズ インコーポレイテッド Compounds with anti-hypertensive, cardioprotective, anti-ischemic and anti-lipolytic properties
WO2001030745A1 (en) * 1999-10-25 2001-05-03 Fujisawa Pharmaceutical Co., Ltd. Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
JP2002275155A (en) * 2001-01-11 2002-09-25 Sankyo Co Ltd Method for producing cyclic amine derivative
WO2003055858A1 (en) * 2001-12-27 2003-07-10 Toray Fine Chemicals Co., Ltd. Process for producing 1-alkoxycarbonyl nitrogenous saturated heterocyclic derivative
WO2004013097A1 (en) * 2002-08-01 2004-02-12 Basilea Pharmaceutica Ag Process for the preparation of amino-pyrrolidine derivatives

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007297306A (en) * 2006-04-28 2007-11-15 Kaneka Corp Method for producing optically active 3-(1-pyrrolidinyl)pyrrolidine
JP2012110373A (en) * 2010-11-19 2012-06-14 Canon Inc Image processing apparatus and image processing method

Similar Documents

Publication Publication Date Title
KR102236806B1 (en) Process for the preparation of enantiomerically enriched 3-aminopiperidine
JP5097770B2 (en) Method for preparing Dorzolamide
JPWO1999033785A1 (en) Methods for producing β-halogeno-α-aminocarboxylic acids, phenylcysteine derivatives, and intermediates thereof
JP5641802B2 (en) Process for producing diastereomeric salt of (S) -4-[(4-chlorophenyl) (2-pyridyl) methoxy] piperidine
JP5164842B2 (en) Process for producing optically active 3-amino nitrogen-containing compound
US10919855B2 (en) Process to prepare n-[2-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulphonyl) ethyl]-1, 3-dioxo-2,3-dihydro-1h-isoindol-4yl]acetamide
JP6947354B2 (en) How to make linagliptin
JP2006022045A (en) METHOD FOR ISOLATING AND PURIFYING OPTICALLY ACTIVE 1-t-BUTOXYCARBONYL-3-AMINOPYRROLIDINE SALT
WO2011010579A1 (en) Process for production of optically active nipecotamide
JPH11349565A (en) Method for producing pyridonecarboxylic acid derivative and intermediate thereof
JP2009023978A (en) Method for producing trans-2-benzyloxycyclohexylamine
EP2735560A1 (en) Method for producing optically active 2-methylproline derivative
JP5397706B2 (en) Method for producing high purity 1-benzyl-3-aminopyrrolidine
JP5503930B2 (en) Method for purifying 3-amino-1-tert-butoxycarbonylpiperidine and citrate salt thereof
JP2007297306A (en) Method for producing optically active 3-(1-pyrrolidinyl)pyrrolidine
JP3884063B2 (en) Cefcapene pivoxil methanesulfonate
RU2741389C1 (en) Method for preparing intermediate compound for synthesis of medicinal agent
JP2008222593A (en) Method for purifying alkylaminopyridine
JP5438976B2 (en) Process for producing optically active 2-arylpiperazine derivatives
CN102245579A (en) The preparation method of (S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
JP4752285B2 (en) Efficient optical resolution of trifluorolactic acid
JP2023548356A (en) Method for purifying noroxymorphone
CN110003113A (en) Method for producing optically active pentanoate derivant
JP2003342259A (en) Method for producing optically active cis-piperidine derivative
WO2007035003A1 (en) Process for producing optically active piperazine compound

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070521

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100928

A02 Decision of refusal

Effective date: 20110208

Free format text: JAPANESE INTERMEDIATE CODE: A02